Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | HTR2B | P41595 | 3/20 | 0.40 |
| ▸ | HTR7 | P34969 | 2/20 | 0.40 |
| ▸ | PNMT | P11086 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 2/20 | 0.34 |
| ▸ | MAOA | P21397 | 2/20 | 0.34 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20920147 | 0.87 | RAB9A (0.47) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL6129764 | 0.83 | RAB9A (0.43) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL4462321 | 0.80 | NPC1 (0.41) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL9449677 | 0.79 | PNMT (0.44) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL2316415 | 0.78 | RAB9A (0.42) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL9420910 | 0.77 | NPC1 (0.50) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL1567119 | 0.77 | NPC1 (0.50) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL30710206 | 0.76 | NPC1 (0.40) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL2231457 | 0.76 | NPC1 (0.47) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL7166662 | 0.76 | PNMT (0.46) | RAB9ANPC1HTR2BHTR7PNMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200146989-A1 | A CO-AMORPHOUS FORM OF A SUBSTANCE AND A DIPEPTIDE | UNIVERSITY OF COPENHAGEN (DK) | 2020-05-14 | — | — | US | disclosed |
| EP-3559016-A1 | A CO-AMORPHOUS FORM OF A SUBSTANCE AND A DIPEPTIDE | University of Copenhagen (DK) | 2019-10-30 | — | — | EP | disclosed |
| WO-2018113891-A1 | A CO-AMORPHOUS FORM OF A SUBSTANCE AND A DIPEPTIDE | UNIVERSITY OF COPENHAGEN (DK) | 2018-06-28 | — | — | WO | disclosed |
| US-9096493-B2 | Preparation method of high-purity L-carnitine | CHANGZHOU MULTIPLE DIMENSION INSTITUTE OF INDUSTRY TECHNOLOGY CO., LTD. (CN) | 2015-08-04 | — | — | US | disclosed |
| EP-2360141-B1 | A PREPARATION METHOD OF HIGH-PURITY L-CARNITINE | CHANGZHOU MULTIPLE DIMENSION INST OF INDUSTRY TECHNOLOGY CO LTD (CN) | 2013-12-11 | — | — | EP | disclosed |
| US-20110263897-A1 | PREPARATION METHOD OF HIGH-PURITY L-CARNITINE | CHANGZHOU MULTIPLE DIMENSION INSTITUTE OF INDUSTRY TECHNOLOGY CO., LTD. (CN) | 2011-10-27 | — | — | US | disclosed |
| EP-2360141-A1 | A PREPARATION METHOD OF HIGH-PURITY L-CARNITINE | Changzhou Multiple Dimension Institute Of Industry Technology Co., Ltd. (CN) | 2011-08-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263897-A1 | PREPARATION METHOD OF HIGH-PURITY L-CARNITINE | CPT2, CRAT, CPT1B | RAB9A 4613/4885NPC1 1230/4885HTR2B 1259/4885 |
| US-20200146989-A1 | A CO-AMORPHOUS FORM OF A SUBSTANCE AND A DIPEPTIDE | DNPEP, PEPD, IDUA | RAB9A 3560/4885NPC1 2281/4885HTR2B 4481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.